Broad PrEP Access in Australia Reduces HIV Infections Even With Reduced Condom Use by People Not on PrEP
A controversial new study is wrongly driving prejudice against PrEP, according to Simon Collins.
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.
A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the risk for preterm birth and early infant death, according to a re-analysis of two studies.
Rob Newells, executive director of the AIDS Project of the East Bay, gives his personal (U.S.-centered, black MSM-focused) highlights from CROI 2018.
After Greece experienced a large increase in the number of new HIV infections among people who inject drugs, organizations launched a program to "seek, test, treat, and retain" in order to put a halt to the outbreak.
Nearly 90 percent of participants in an open-label study of a vaginal ring infused with a drug to prevent HIV are using the monthly ring at least some of the time, according to data presented at CROI 2018.
A summary of key facts and statistics about HIV in correctional settings.
A new study reports how earlier prejudice against people who use PrEP has largely been overcome among users of social media hook-up apps in four large U.S. cities.
In our final installment of 2017, we intermingle forward-looking research with some retrospective analysis. We begin our four-study tour by joining researchers in Tennessee for an exercise in HIV outbreak prediction.
"The stigma, fear and ignorance associated with HIV are still very strong; those of us who do this work on a daily basis might forget this sad fact," Paul Sax, M.D., writes.